Variant report
Variant | esv3418934 |
---|---|
Chromosome Location | chr5:17480152-17482050 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr5:17481912-17481950 | Medullo | brain: | n/a | n/a |
2 | CTCF | chr5:17481839-17481971 | GM12878 | blood: | n/a | n/a |
3 | CTCF | chr5:17481860-17482010 | Caco-2 | colon: | n/a | n/a |
4 | CTCF | chr5:17481700-17481850 | A549 | lung: | n/a | n/a |
5 | CTCF | chr5:17481740-17481890 | Hela-S3 | cervix: | n/a | n/a |
6 | CTCF | chr5:17481912-17482004 | MCF-7 | breast: | n/a | n/a |
7 | CTCF | chr5:17481780-17481930 | MCF-7 | breast: | n/a | n/a |
8 | CTCF | chr5:17481880-17482030 | MCF-7 | breast: | n/a | n/a |
9 | CTCF | chr5:17481780-17481930 | A549 | lung: | n/a | n/a |
10 | CTCF | chr5:17481900-17482050 | BE2_C | brain: | n/a | n/a |
11 | CTCF | chr5:17481840-17481990 | BE2_C | brain: | n/a | n/a |
12 | CTCF | chr5:17481946-17481996 | Hela-S3 | cervix: | n/a | n/a |
13 | CTCF | chr5:17481862-17482016 | Gliobla | brain: | n/a | n/a |
14 | GTF2F1 | chr5:17481644-17481658 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | RAD21 | chr5:17481791-17482112 | Hela-S3 | cervix: | n/a | chr5:17481947-17481954 |
16 | RAD21 | chr5:17481792-17482101 | H1-hESC | embryonic stem cell: | n/a | chr5:17481947-17481954 |
17 | RAD21 | chr5:17481848-17482136 | H1-hESC | embryonic stem cell: | n/a | chr5:17481947-17481954 |
18 | SMC3 | chr5:17481846-17482108 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251304 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558673822 | chr5:17480170-17480171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372186917 | chr5:17480231-17480232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569412518 | chr5:17480241-17480242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs538090548 | chr5:17480252-17480253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555160675 | chr5:17480266-17480267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111275858 | chr5:17480287-17480288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs71601746 | chr5:17480309-17480310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs386403147 | chr5:17480324-17480325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34591461 | chr5:17480325-17480326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371908901 | chr5:17480338-17480339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375253322 | chr5:17480340-17480341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111769007 | chr5:17480366-17480367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114673370 | chr5:17480394-17480395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs36068391 | chr5:17480397-17480398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs398083958 | chr5:17480410-17480411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs397883156 | chr5:17480411-17480412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199938553 | chr5:17480414-17480415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115541518 | chr5:17480434-17480435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545101848 | chr5:17480466-17480467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565004471 | chr5:17480471-17480472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146167634 | chr5:17480476-17480477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73756919 | chr5:17480500-17480501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs111294310 | chr5:17480510-17480511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116075643 | chr5:17480536-17480537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546533203 | chr5:17480552-17480553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111939199 | chr5:17480559-17480560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532400922 | chr5:17480603-17480604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552237281 | chr5:17480642-17480643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569219220 | chr5:17480709-17480710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538339866 | chr5:17480745-17480746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185321902 | chr5:17480771-17480772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564997328 | chr5:17480774-17480775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568677816 | chr5:17480805-17480806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190268640 | chr5:17480830-17480831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139318132 | chr5:17480834-17480835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554530715 | chr5:17480862-17480863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536818719 | chr5:17480893-17480894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372183510 | chr5:17480915-17480916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201115298 | chr5:17480917-17480918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs112152372 | chr5:17480921-17480922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs199899446 | chr5:17480927-17480928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs67178611 | chr5:17480928-17480929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201137024 | chr5:17480931-17480932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs70947606 | chr5:17480935-17480936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544984397 | chr5:17480986-17480987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs202076354 | chr5:17480991-17480992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558542894 | chr5:17481010-17481011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575205590 | chr5:17481106-17481107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72740570 | chr5:17481173-17481174 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs116140458 | chr5:17481184-17481185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 21364760 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Melanoma | 22183965 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 19287141 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:17476400-17486200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
2 | chr5:17480600-17480800 | Enhancers | Fetal Kidney | kidney |
3 | chr5:17481400-17481600 | Enhancers | Fetal Kidney | kidney |
4 | chr5:17481400-17482000 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr5:17481400-17482000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr5:17481400-17482000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr5:17481400-17482000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr5:17481400-17482000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr5:17481400-17482200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr5:17481400-17483000 | Enhancers | A549 | lung |
11 | chr5:17481600-17481800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr5:17481600-17482000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr5:17481600-17482000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr5:17481600-17482000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |